Shares of HCP, Inc. (NYSE:HCP) have earned an average rating of “Hold” from the seventeen research firms that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating on the company. The average twelve-month price target among analysts that have updated their coverage on the stock in the last year is $26.70.
A number of analysts recently issued reports on HCP shares. JPMorgan Chase & Co. downgraded HCP from an “overweight” rating to a “neutral” rating in a research report on Friday, October 5th. Cantor Fitzgerald raised HCP from a “neutral” rating to an “overweight” rating and raised their price objective for the stock from $28.00 to $29.00 in a research report on Thursday, September 27th. Royal Bank of Canada raised HCP from a “sector perform” rating to an “outperform” rating in a research report on Friday, November 2nd. Bank of America raised their price objective on HCP from $27.50 to $28.00 and gave the stock a “buy” rating in a research report on Monday, September 17th. Finally, BMO Capital Markets reissued a “hold” rating and set a $27.00 price objective on shares of HCP in a research report on Wednesday, October 31st.
In related news, COO Thomas Klaritch sold 82,532 shares of the firm’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $29.51, for a total transaction of $2,435,519.32. Following the completion of the transaction, the chief operating officer now directly owns 256,280 shares in the company, valued at approximately $7,562,822.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.14% of the company’s stock.
A number of institutional investors have recently made changes to their positions in the stock. Carnegie Capital Asset Management LLC boosted its holdings in HCP by 29.7% during the 3rd quarter. Carnegie Capital Asset Management LLC now owns 10,925 shares of the real estate investment trust’s stock valued at $317,000 after acquiring an additional 2,500 shares during the period. Vanguard Group Inc. boosted its holdings in HCP by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 75,247,949 shares of the real estate investment trust’s stock valued at $1,980,527,000 after acquiring an additional 196,049 shares during the period. Legal & General Group Plc boosted its holdings in HCP by 1.2% during the 3rd quarter. Legal & General Group Plc now owns 3,690,653 shares of the real estate investment trust’s stock valued at $97,108,000 after acquiring an additional 44,998 shares during the period. Standard Life Aberdeen plc boosted its holdings in HCP by 3.3% during the 3rd quarter. Standard Life Aberdeen plc now owns 249,259 shares of the real estate investment trust’s stock valued at $6,562,000 after acquiring an additional 7,990 shares during the period. Finally, Rehmann Capital Advisory Group boosted its holdings in HCP by 2,572.2% during the 3rd quarter. Rehmann Capital Advisory Group now owns 26,188 shares of the real estate investment trust’s stock valued at $995,000 after acquiring an additional 25,208 shares during the period. Institutional investors own 90.00% of the company’s stock.
Shares of HCP traded down $0.36 during midday trading on Friday, reaching $29.87. The company had a trading volume of 3,379,803 shares, compared to its average volume of 3,562,119. HCP has a 1-year low of $21.48 and a 1-year high of $30.26. The company has a market capitalization of $13.67 billion, a PE ratio of 15.32, a price-to-earnings-growth ratio of 7.33 and a beta of 0.23. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 1.21.
HCP (NYSE:HCP) last issued its quarterly earnings data on Wednesday, October 31st. The real estate investment trust reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. The firm had revenue of $456.00 million during the quarter, compared to the consensus estimate of $456.59 million. HCP had a return on equity of 3.06% and a net margin of 9.16%. The company’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the company earned $0.48 EPS. As a group, equities analysts anticipate that HCP will post 1.82 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Monday, November 5th were issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 4.95%. The ex-dividend date was Friday, November 2nd. HCP’s dividend payout ratio (DPR) is 75.90%.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
See Also: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.